Turnstone Biologics Files 2024 10-K
| Field | Detail |
|---|---|
| Company | Turnstone Biologics Corp. |
| Form Type | 10-K |
| Filed Date | Mar 31, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, financials, biologics
TL;DR
Turnstone Biologics filed its 2024 10-K. Full financials and strategy details inside.
AI Summary
Turnstone Biologics Corp. filed its 2024 10-K on March 31, 2025, reporting its financial performance for the fiscal year ending December 31, 2024. The company, focused on biological products, is headquartered in La Jolla, California. Key financial details and operational highlights from the filing are not explicitly detailed in the provided text, but it references various accounting standards and agreements, including a Takeda Agreement.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Turnstone Biologics' financial health, operational performance, and strategic direction for the fiscal year 2024.
Risk Assessment
Risk Level: medium — The filing is a standard 10-K, but the lack of specific financial performance data in the provided snippet necessitates a medium risk assessment for detailed analysis.
Key Players & Entities
- Turnstone Biologics Corp. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-03-31 (date) — Filing date
- La Jolla, CA (location) — Business address
- Takeda Agreement (agreement) — Mentioned in filing
FAQ
What were Turnstone Biologics Corp.'s total revenues for the fiscal year ending December 31, 2024?
The provided text does not explicitly state the total revenues for the fiscal year ending December 31, 2024.
What were the total operating expenses for Turnstone Biologics Corp. in fiscal year 2024?
The provided text references 'OperatingExpenses' but does not specify the dollar amount for fiscal year 2024.
What is the nature of the 'Takeda Agreement' mentioned in the filing?
The provided text mentions the 'TakedaAgreement' in the context of 'ClinicalAndRegulatory' but does not detail the specific terms or nature of the agreement.
When was the company incorporated or organized?
The provided text indicates the 'STATE OF INCORPORATION' is 'DE' but does not provide a specific incorporation date.
What are the key performance indicators or financial highlights Turnstone Biologics Corp. is reporting for 2024?
The provided text does not contain specific financial performance data or key highlights for Turnstone Biologics Corp. for the 2024 fiscal year.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 31, 2025 regarding Turnstone Biologics Corp..